Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Fungal Allergenic Extract [EPC]
Human Herpesvirus 1 (HHV-1) is a biological agent primarily utilized as a non-standardized allergenic extract for diagnostic and therapeutic purposes. It is used to evaluate cell-mediated immunity and as a component in complex immunological panels.
Name
Human Herpesvirus 1
Raw Name
HUMAN HERPESVIRUS 1
Category
Non-Standardized Fungal Allergenic Extract [EPC]
Drug Count
21
Variant Count
22
Last Verified
February 17, 2026
About Human Herpesvirus 1
Human Herpesvirus 1 (HHV-1) is a biological agent primarily utilized as a non-standardized allergenic extract for diagnostic and therapeutic purposes. It is used to evaluate cell-mediated immunity and as a component in complex immunological panels.
Detailed information about Human Herpesvirus 1
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Human Herpesvirus 1.
Human Herpesvirus 1 (HHV-1), traditionally known as Herpes Simplex Virus Type 1 (HSV-1), is a member of the Herpesviridae family. In the context of clinical pharmacology and the FDA's regulatory framework, Human Herpesvirus 1 is categorized as a Non-Standardized Fungal Allergenic Extract [EPC], although it is biologically a virus. This classification often stems from its historical and contemporary use in skin testing panels alongside fungal antigens (such as Candida or Trichophyton) to assess a patient's cell-mediated immunity (CMI).
HHV-1 belongs to a broad class of biological products used for the diagnosis and treatment of allergic and immunologic conditions. While most commonly recognized as the causative agent of oral herpes (cold sores), its pharmaceutical preparation as an extract involves the inactivation of the virus to create a sterile solution of viral antigens. According to the FDA's biological product guidelines, these extracts are used to provoke a controlled immune response. The approval history of such extracts dates back to the early 20th century under the Biologics Control Act, with modern refinements ensuring high standards of purity and safety, though they remain 'non-standardized' because their potency is not measured against a national reference standard.
When used as a diagnostic or therapeutic agent, Human Herpesvirus 1 works by stimulating the body's immune system, specifically the T-lymphocytes. At the molecular level, the extract contains viral glycoproteins (such as gB, gC, gD, and gE) and other structural proteins. When injected intradermally (into the skin), these antigens are captured by specialized cells called dendritic cells (antigen-presenting cells).
These dendritic cells process the HHV-1 antigens and present them to T-cells. If the patient has been previously exposed to HHV-1—which is true for the vast majority of the global adult population—memory T-cells will recognize the antigen. This recognition triggers a 'Delayed-Type Hypersensitivity' (DTH) reaction. This reaction involves the release of pro-inflammatory cytokines, such as Interferon-gamma (IFN-γ) and Interleukin-2 (IL-2), which recruit more immune cells to the site of injection. This results in a visible and palpable swelling (induration) and redness (erythema) within 48 to 72 hours. This process allows healthcare providers to confirm that the patient's cellular immune system is functioning correctly. If a patient fails to react to a battery of such antigens (a state called 'anergy'), it may indicate a severely compromised immune system, such as in cases of advanced HIV/AIDS, certain cancers, or malnutrition.
As a biological extract administered via local injection, the pharmacokinetics of Human Herpesvirus 1 differ significantly from traditional small-molecule drugs.
Human Herpesvirus 1 extract is utilized in several specific clinical scenarios:
Human Herpesvirus 1 is typically available in the following forms:
> Important: Only your healthcare provider can determine if Human Herpesvirus 1 is right for your specific condition. The use of biological extracts requires specialized clinical training to ensure accurate administration and interpretation of results.
The dosage for Human Herpesvirus 1 extract is highly individualized and depends on the purpose of the test (diagnostic vs. therapeutic).
Human Herpesvirus 1 extract can be used in children, particularly to evaluate suspected primary immunodeficiency disorders.
No dosage adjustments are typically required for patients with kidney disease, as the extract is not cleared through renal filtration in a way that would cause systemic toxicity.
No dosage adjustments are necessary for patients with liver disease. The metabolic pathway of viral antigens does not involve hepatic enzymes.
Elderly patients (65 years and older) may exhibit 'immunosenescence' (a natural weakening of the immune system). This can lead to false-negative results (anergy). While the dose remains the same, the interpretation of the skin test must account for the patient's age and overall health status.
Human Herpesvirus 1 extract is never self-administered. It must be administered by a trained healthcare professional (usually an allergist, immunologist, or nurse) in a clinical setting equipped to handle allergic emergencies.
Since this is typically a one-time diagnostic test, a 'missed dose' usually refers to a missed appointment for the 48-72 hour reading. If the reading is missed, the test may need to be repeated on the opposite arm, as the reaction peaks and then fades. For immunotherapy, if a maintenance dose is missed, contact your allergist immediately; you may need to 'back up' to a lower dose to ensure safety.
An overdose of Human Herpesvirus 1 extract is rare but can occur if the wrong concentration is used or if it is accidentally injected into a vein (intravenously) rather than into the skin.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to interpret your own skin test results without medical guidance.
Most patients receiving a Human Herpesvirus 1 extract injection will experience some level of local reaction. These are generally expected and indicate that the immune system is responding to the antigen.
> Warning: Stop taking Human Herpesvirus 1 and call your doctor immediately if you experience any of these symptoms of a systemic allergic reaction.
Because Human Herpesvirus 1 extract is typically used for short-term diagnostic testing, long-term side effects are extremely rare. However, repeated exposure to the antigen through frequent testing or immunotherapy could potentially lead to 'sensitization.' This means a person who previously had no reaction might develop an allergy to the extract itself. There is no evidence that the inactivated extract can cause a chronic herpes infection or lead to the development of cold sores, as the virus is not live.
No FDA black box warnings currently exist for Human Herpesvirus 1 non-standardized extracts. However, all allergenic extracts carry an implicit warning regarding the risk of severe systemic reactions. According to the American Academy of Allergy, Asthma & Immunology (AAAAI), any procedure involving the injection of an allergen must be performed in a facility capable of treating anaphylaxis.
Report any unusual symptoms, especially those occurring within the first hour of injection, to your healthcare provider immediately. If you leave the clinic and experience swelling of the throat or difficulty breathing, call 911 or your local emergency services.
Human Herpesvirus 1 extract is a potent biological product. It is intended only for use by physicians who are experienced in the administration of allergenic extracts and the assessment of cell-mediated immunity. Patients must be screened for a history of severe reactions to previous skin tests or herpes infections before administration.
No FDA black box warnings for Human Herpesvirus 1. While some standardized extracts (like those for bee stings or certain grasses) have specific boxed warnings, HHV-1 as a non-standardized extract is governed by general biologics safety standards which emphasize the risk of anaphylaxis.
Human Herpesvirus 1 extract generally does not affect the ability to drive or operate machinery. However, if a patient experiences a vasovagal response (dizziness or fainting) after the needle stick, they should wait until they feel fully recovered before leaving the clinic.
There are no known direct interactions between alcohol and Human Herpesvirus 1 extract. However, alcohol can cause vasodilation (widening of blood vessels), which might theoretically increase the redness at the injection site or mask a mild systemic reaction. It is best to avoid heavy alcohol consumption for 24 hours after the test.
Since this is a diagnostic test, 'discontinuation' is not applicable in the traditional sense. For those on an immunotherapy regimen, stopping the injections will result in a gradual loss of the desensitization effect. There is no 'withdrawal syndrome' associated with stopping HHV-1 extracts.
> Important: Discuss all your medical conditions, especially any history of fainting or severe allergic reactions, with your healthcare provider before starting Human Herpesvirus 1 testing.
There are no drugs that are strictly 'contraindicated' in the sense of causing a lethal chemical reaction. However, several medications will make the Human Herpesvirus 1 test medically useless by suppressing the immune response:
There are no documented interactions between Human Herpesvirus 1 extract and specific foods. Patients do not need to fast before the test. However, avoid trying new or highly allergenic foods on the day of the test so that any systemic reaction can be clearly attributed to the injection.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those that affect your immune system or blood pressure.
Human Herpesvirus 1 extract must NEVER be used in the following circumstances:
In these cases, the healthcare provider will perform a careful risk-benefit analysis:
Patients who are highly sensitive to other viruses in the Herpesviridae family—such as Human Herpesvirus 2 (HSV-2) or Varicella-Zoster Virus (VZV/Chickenpox)—may show an exaggerated response to the HHV-1 extract. This is due to 'homology,' where the proteins in these viruses are structurally similar enough that the immune system confuses one for the other.
> Important: Your healthcare provider will evaluate your complete medical history, including your vaccination record and any history of herpes infections, before prescribing Human Herpesvirus 1 extract.
FDA Pregnancy Category C. Animal reproduction studies have not been conducted with Human Herpesvirus 1 extract. It is also not known whether the extract can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
It is not known whether HHV-1 antigens or the antibodies produced in response to the test are excreted in human milk. However, because the viral proteins are inactivated and the dose is minimal, the risk to a nursing infant is considered negligible. The benefits of breastfeeding generally outweigh any theoretical risks from a maternal skin test.
Human Herpesvirus 1 extract is used in pediatric patients to evaluate the integrity of the cellular immune system.
In patients over 65, the prevalence of HHV-1 antibodies is high, but the T-cell response often diminishes.
No specific studies have been performed in patients with renal impairment. However, since the clearance of the extract is local and proteolytic, kidney function does not significantly impact the safety or efficacy of the test. Dialysis does not remove the antigens from the skin site.
Liver disease (including cirrhosis) does not affect the metabolism of HHV-1 extract. No dosage adjustments are required for patients with Child-Pugh Class A, B, or C hepatic impairment.
> Important: Special populations require individualized medical assessment. Ensure your provider is aware of your pregnancy status or any age-related health concerns.
Human Herpesvirus 1 extract functions as a diagnostic probe for cell-mediated (Type IV) immunity. The mechanism involves several distinct steps:
| Parameter | Value |
|---|---|
| Bioavailability | Negligible (Local administration) |
| Protein Binding | N/A (Viral proteins) |
| Half-life | 24-48 hours (at injection site) |
| Tmax | 48-72 hours (for clinical effect) |
| Metabolism | Proteolytic degradation by macrophages |
| Excretion | Lymphatic clearance |
Human Herpesvirus 1 is classified as a Non-Standardized Fungal Allergenic Extract [EPC] in some regulatory databases, though it is more accurately described as a Viral Diagnostic Antigen. It shares clinical similarities with the Tuberculin Purified Protein Derivative (PPD) and Mumps Skin Test Antigen (MSTA).
Medications containing this ingredient
Common questions about Human Herpesvirus 1
Human Herpesvirus 1 extract is primarily used as a diagnostic tool to check if a person's immune system is working correctly. Specifically, it tests 'cell-mediated immunity,' which is the part of the immune system that uses T-cells to fight infections. By injecting a small amount of inactivated virus into the skin, doctors can see if the body recognizes it and mounts a small, controlled defense. This is often called a 'recall antigen' test because it relies on the immune system 'recalling' a previous exposure to the virus. It is a standard part of evaluating patients who might have immune deficiency disorders.
The most common side effects are localized to the area where the injection was given. Patients typically experience redness, itching, and a hard, raised bump (induration) at the site on the forearm. These symptoms usually peak about two to three days after the test and are a sign that the test is working. Some people may also experience mild soreness or a very slight fever. Most of these effects go away on their own within a week without any special treatment. If the swelling becomes very large or painful, you should contact your healthcare provider.
There is no direct medical interaction between alcohol and the Human Herpesvirus 1 extract. However, it is generally recommended to avoid heavy drinking for at least 24 to 48 hours after the injection. Alcohol can cause your blood vessels to dilate, which might make the redness at the injection site look worse than it actually is. Additionally, alcohol can sometimes mask the early signs of a more serious allergic reaction, such as dizziness or flushing. To ensure the most accurate test result and your own safety, moderation is key. Always follow the specific advice given by your clinic.
Human Herpesvirus 1 extract is classified as Pregnancy Category C, which means its safety has not been deeply studied in pregnant women. While the extract is inactivated and unlikely to harm the baby directly, the main concern is the risk of a severe allergic reaction (anaphylaxis) in the mother. If a mother has a severe reaction, it could temporarily reduce oxygen flow to the fetus. Because of this, most doctors will only perform this test during pregnancy if it is absolutely necessary for a diagnosis. If you are pregnant or planning to become pregnant, be sure to discuss the risks and benefits with your doctor.
The Human Herpesvirus 1 skin test is a 'delayed-type' reaction, meaning it takes time for the immune system to respond. You will not see an immediate result like you might with a standard allergy 'prick' test. The reaction typically starts to become visible after about 24 hours, but it reaches its maximum size between 48 and 72 hours. This is why your doctor will ask you to return to the clinic exactly two or three days after the injection. If you look at the spot too early or too late, the test result might be interpreted incorrectly.
Human Herpesvirus 1 is almost always given as a single-dose diagnostic test rather than a long-term medication. Therefore, 'stopping' the medication is not usually an issue. If you are part of a rare immunotherapy program using this extract and decide to stop, you can do so without experiencing withdrawal symptoms. However, stopping immunotherapy will mean you lose the immune-boosting or desensitizing benefits of the treatment. You should never stop a prescribed course of immunotherapy without first consulting your allergist, as they may need to adjust your treatment plan.
In the context of a diagnostic skin test, a 'missed dose' usually means you missed the appointment to have your skin reaction read by the doctor. If you miss the 48-to-72-hour window, the test result may no longer be accurate because the swelling might have started to go down. In this case, you will likely need to have the test repeated, usually on your other arm. If you are receiving the extract as part of a series of immunotherapy injections and miss a dose, call your doctor's office immediately to reschedule. They will tell you if you need to repeat a previous dose level for safety.
No, there is no evidence that Human Herpesvirus 1 extract causes weight gain. Unlike some systemic medications like oral steroids or certain antidepressants, this biological extract is administered in a very small amount and acts primarily at the site of injection. It does not affect your metabolism, appetite, or fat storage. Any weight changes you experience while undergoing testing are likely due to other factors, such as diet, exercise, or other medications you may be taking. If you have concerns about weight changes, discuss them with your primary care physician.
Human Herpesvirus 1 can be given while you are taking most medications, but some drugs can interfere with the test results. For example, high doses of steroids (like Prednisone) or immune-suppressing drugs used for cancer or autoimmune diseases can cause a 'false negative' result. This means the test says your immune system is weak when it might just be suppressed by the drugs. Antihistamines can also slightly reduce the redness of the reaction. It is very important to give your doctor a full list of all your current medications before the test so they can interpret the results correctly.
Human Herpesvirus 1 extract is a biological product, and the concept of 'generic' versions is different for biologics than for standard pills. Because these are complex extracts made from living cells, they are usually referred to by their brand names or simply as 'Non-Standardized Allergenic Extracts.' There are several different manufacturers that produce these extracts under various laboratory labels. While they all contain the same basic viral antigens, they are not always considered identical. Your doctor will choose a reputable manufacturer that meets FDA standards for biological products.